S
18.28
-0.71 (-3.74%)
| 前收盘价格 | 18.99 |
| 成交量 | 348,939 |
| 预期市盈率 (P/E Forward) | 18.74 |
| 价格/销量 (P/S) | 1.06 |
| 股市价格/股市净资产 (P/B) | 1.28 |
| 52周波幅 |
| 营业毛利率 | -11.12% |
| 营业利益率 (TTM) | -40.33% |
| 稀释每股收益 (EPS TTM) | -2.64 |
| 季度收入增长率 (YOY) | 80.20% |
| 季度盈利增长率 (YOY) | 248.40% |
| 总债务/股东权益 (D/E MRQ) | 118.73% |
| 流动比率 (MRQ) | 4.02 |
| 营业现金流 (OCF TTM) | -547.15 M |
| 杠杆自由现金流 (LFCF TTM) | -741.26 M |
| 资产报酬率 (ROA TTM) | -2.19% |
| 股东权益报酬率 (ROE TTM) | -23.61% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | Sarepta Therapeutics, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -1.1 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | 2.0 |
| 相对估值 | NA |
| 财务健康 | -1.5 |
| 宏观环境 | -1.3 |
| AI Insight | NA |
| AI Technical | NA |
| 平均 | 0.70 |
|
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 4.42% |
| 机构持股比例 | 96.33% |
该时间范围内无数据。
该时间范围内无数据。
投资组合